Dermata Therapeutics Ownership 2024 | Who Owns Dermata Therapeutics Now?

Overview ForecastFinancials Chart

Institutional Ownership

38.16%

Insider Ownership

1.30%

Retail Ownership

60.54%

Institutional Holders

11.00

Dermata Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	8.48%	-	26,400	26,400	100.00%	34,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	1.87%	0.00%	5,808	5,808	100.00%	7,000	Mar 31, 2023
UBS GROUP AG	1.11%	-	3,445	3,445	100.00%	4,444,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.49%	-	1,526	1,526	100.00%	1,969,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-778	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-1,528	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-293	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,667	-100.00%	-	Mar 31, 2023
SAGE CAPITAL ADVISORS,LLC	-	-	-	-750	-100.00%	-	Mar 31, 2023
HC ADVISORS, LLC	-	-	-	-625	-100.00%	-	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-8,861	-100.00%	-	Mar 31, 2023
FAS WEALTH PARTNERS, INC.	-	-	-	-794	-100.00%	-	Mar 31, 2023
TUDOR INVESTMENT CORP ET AL	-	-	-	-638	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-36	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,332	-100.00%	-	Mar 31, 2023

Dermata Therapeutics's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 8.48% of the company's total share outstanding, currently valued at $34.00K. The top 10 institutional shareholders own together 11.94% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TOWER RESEARCH CAPITAL LLC (TRC)	1.87%	0.00%	5,808	5,808	100.00%	7,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	8.48%	-	26,400	26,400	100.00%	34,000	Mar 31, 2023
UBS GROUP AG	1.11%	-	3,445	3,445	100.00%	4,444,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.49%	-	1,526	1,526	100.00%	1,969,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-778	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-1,528	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-293	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,667	-100.00%	-	Mar 31, 2023
SAGE CAPITAL ADVISORS,LLC	-	-	-	-750	-100.00%	-	Mar 31, 2023
HC ADVISORS, LLC	-	-	-	-625	-100.00%	-	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-8,861	-100.00%	-	Mar 31, 2023
FAS WEALTH PARTNERS, INC.	-	-	-	-794	-100.00%	-	Mar 31, 2023
TUDOR INVESTMENT CORP ET AL	-	-	-	-638	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-36	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,332	-100.00%	-	Mar 31, 2023

The largest Dermata Therapeutics shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 5.81K shares of Dermata Therapeutics (DRMA), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	8.48%	-	26,400	26,400	100.00%	34,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	1.87%	0.00%	5,808	5,808	100.00%	7,000	Mar 31, 2023
UBS GROUP AG	1.11%	-	3,445	3,445	100.00%	4,444,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.49%	-	1,526	1,526	100.00%	1,969,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-36	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-293	-100.00%	-	Mar 31, 2023
HC ADVISORS, LLC	-	-	-	-625	-100.00%	-	Mar 31, 2023
TUDOR INVESTMENT CORP ET AL	-	-	-	-638	-100.00%	-	Mar 31, 2023
SAGE CAPITAL ADVISORS,LLC	-	-	-	-750	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-778	-100.00%	-	Mar 31, 2023
FAS WEALTH PARTNERS, INC.	-	-	-	-794	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-1,528	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,667	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,332	-100.00%	-	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-8,861	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Dermata Therapeutics's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 26.40K stocks of DRMA, valued at $34.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-8,861	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,332	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,667	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-1,528	-100.00%	-	Mar 31, 2023
FAS WEALTH PARTNERS, INC.	-	-	-	-794	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-778	-100.00%	-	Mar 31, 2023
SAGE CAPITAL ADVISORS,LLC	-	-	-	-750	-100.00%	-	Mar 31, 2023
TUDOR INVESTMENT CORP ET AL	-	-	-	-638	-100.00%	-	Mar 31, 2023
HC ADVISORS, LLC	-	-	-	-625	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-293	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-36	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.49%	-	1,526	1,526	100.00%	1,969,000	Mar 31, 2023
UBS GROUP AG	1.11%	-	3,445	3,445	100.00%	4,444,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	1.87%	0.00%	5,808	5,808	100.00%	7,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	8.48%	-	26,400	26,400	100.00%	34,000	Mar 31, 2023

As of Mar 31 2023, Dermata Therapeutics's biggest institutional seller is RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.. The company sold -8.86K shares of DRMA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	8.48%	-	26,400	26,400	100.00%	34,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	1.87%	0.00%	5,808	5,808	100.00%	7,000	Mar 31, 2023
UBS GROUP AG	1.11%	-	3,445	3,445	100.00%	4,444,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.49%	-	1,526	1,526	100.00%	1,969,000	Mar 31, 2023

Dermata Therapeutics's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 26.40K shares, valued at $34.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	-	-	-	-8,861	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,332	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-1,667	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-1,528	-100.00%	-	Mar 31, 2023
FAS WEALTH PARTNERS, INC.	-	-	-	-794	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-778	-100.00%	-	Mar 31, 2023
SAGE CAPITAL ADVISORS,LLC	-	-	-	-750	-100.00%	-	Mar 31, 2023
TUDOR INVESTMENT CORP ET AL	-	-	-	-638	-100.00%	-	Mar 31, 2023
HC ADVISORS, LLC	-	-	-	-625	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-293	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-36	-100.00%	-	Mar 31, 2023

Dermata Therapeutics's largest sold out institutional shareholder by shares sold is RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC., sold -8.86K shares, valued at -, as of undefined.

Dermata Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	26,629	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	12,237	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	1,718	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	17,157	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	512	-	-	Mar 31, 2024

Dermata Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 26.63K shares, compromising 0.00% of its total assets.

Dermata Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 22	11	22.22%
30 Sep, 22	9	-10.00%
30 Jun, 22	10	42.86%
31 Mar, 22	7	-30.00%
31 Dec, 21	10	25.00%
30 Sep, 21	8	-

As of 31 Dec 22, 11 institutions are holding Dermata Therapeutics's shares, representing an increase of 22.22% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 22	292,762	48.44%
30 Sep, 22	197,232	-76.89%
30 Jun, 22	853,449	1074.14%
31 Mar, 22	72,687	-44.17%
31 Dec, 21	130,204	-50.67%
30 Sep, 21	263,947	-

Dermata Therapeutics (DRMA) has 292.76K shares outstanding as of 31 Dec 22, up 48.44% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 22	38.16%	5.77%
30 Sep, 22	25.71%	0.17%
30 Jun, 22	121.98%	62.91%
31 Mar, 22	13.92%	0.59%
31 Dec, 21	48.42%	0.50%
30 Sep, 21	98.16%	-

As of 31 Dec 22, Dermata Therapeutics is held by 38.16% institutional shareholders, representing a 5.77% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 22	7	40.00%
30 Sep, 22	5	-37.50%
30 Jun, 22	8	100.00%
31 Mar, 22	4	-55.56%
31 Dec, 21	9	28.57%
30 Sep, 21	7	-

7 institutional shareholders have increased their position in DRMA stock as of 31 Dec 22 compared to 5 in the previous quarter (a 40.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 22	1	-
30 Sep, 22	1	-
30 Jun, 22	-	-100.00%
31 Mar, 22	1	-
31 Dec, 21	1	-
30 Sep, 21	-	-

1 institutional shareholders have reduced their position in DRMA stock as of 31 Dec 22 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 22	11	22.22%	292,762	48.44%	38.16%	5.77%	7	40.00%	1	-
30 Sep, 22	9	-10.00%	197,232	-76.89%	25.71%	0.17%	5	-37.50%	1	-
30 Jun, 22	10	42.86%	853,449	1074.14%	121.98%	62.91%	8	100.00%	-	-100.00%
31 Mar, 22	7	-30.00%	72,687	-44.17%	13.92%	0.59%	4	-55.56%	1	-
31 Dec, 21	10	25.00%	130,204	-50.67%	48.42%	0.50%	9	28.57%	1	-
30 Sep, 21	8	-	263,947	-	98.16%	-	7	-	-	-

Dermata Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 05, 2024	Mento Steven J	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	PROEHL GERALD T	director, officer	President, CEO and Chairman	A-Award	Buy	125,000	$0.61	$76.24K	125,000
Jan 05, 2024	FISHER MARY	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	Scott Kathleen D.	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	Sandler Andrew Seth	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	Nardo Christopher J.	officer	Senior VP, CDO	A-Award	Buy	50,000	$0.61	$30.50K	50,000
Jan 05, 2024	WIERENGA WENDELL	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	HALE DAVID F	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	Bradrick Brittany	director	-	A-Award	Buy	10,000	$0.61	$6.10K	10,000
Jan 05, 2024	Van Hoose Kyri K.	officer	SVP, CFO	A-Award	Buy	50,000	$0.61	$30.50K	50,000
Jan 05, 2024	Bedoya-Toro Munera Maria E	officer	SVP, Regulatory Affairs	A-Award	Buy	25,000	$0.61	$15.25K	25,000
Jan 05, 2023	Bedoya-Toro Munera Maria E	director	SVP, Regulatory Affairs	A-Award	Buy	50,000	-	-	50,000
Jan 05, 2023	Van Hoose Kyri K.	director	SVP, CFO	A-Award	Buy	100,000	-	-	100,000
Jan 05, 2023	Nardo Christopher J.	director	Senior VP, CDO	A-Award	Buy	100,000	-	-	100,000
Oct 07, 2022	Sandler Andrew Seth	director	-	A-Award	Buy	10,120	-	-	24,184
Oct 07, 2022	Bradrick Brittany	director	-	A-Award	Buy	9,810	-	-	23,443
Oct 07, 2022	HALE DAVID F	director	-	A-Award	Buy	30,155	-	-	75,720
Oct 07, 2022	FISHER MARY	director	-	A-Award	Buy	9,810	-	-	23,443
Oct 07, 2022	Scott Kathleen D.	director	-	A-Award	Buy	11,359	-	-	27,145
Oct 07, 2022	WIERENGA WENDELL	director	-	A-Award	Buy	20,654	-	-	62,398

Dermata Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	11	-	-
Q1 2023	3	-	-
Q4 2022	6	-	-
Q3 2022	7	-	-
Q2 2022	6	-	-
Q3 2021	39	15	260.00%

11 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Dermata Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q3 2021	4	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Dermata Therapeutics's stocks.

Dermata Therapeutics Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
ENSC	Ensysce Biosciences, Inc.
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
AVRO	AVROBIO, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
WINT	Windtree Therapeutics, Inc.
HEPA	Hepion Pharmaceuticals, Inc.
BXRX	Baudax Bio, Inc.
ZURA	Zura Bio Limited
CDIO	Cardio Diagnostics Holdings, Inc.
ATNF	180 Life Sciences Corp.

DRMA Ownership FAQ

Who Owns Dermata Therapeutics?

Dermata Therapeutics is owned by institutional shareholders (38.16%), insiders (1.30%), and public (60.54%). The largest institutional shareholder of Dermata Therapeutics is RENAISSANCE TECHNOLOGIES LLC (8.48% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Dermata Therapeutics?

Dermata Therapeutics's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, TOWER RESEARCH CAPITAL LLC (TRC), UBS GROUP AG, WELLS FARGO & COMPANY/MN, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 11.94% of the company's share outstanding.

How many Dermata Therapeutics shareholders are there?

As of Dec 2022, there are 11 institutional shareholders of Dermata Therapeutics.

What percentage of Dermata Therapeutics is owned by RENAISSANCE TECHNOLOGIES LLC?

RENAISSANCE TECHNOLOGIES LLC owns 26.4K shares of Dermata Therapeutics, representing 8.48% of the company's total shares outstanding, valued at $34K (as of Mar 2023).

What percentage of Dermata Therapeutics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?

As of Mar 2023, TOWER RESEARCH CAPITAL LLC (TRC) holds 5.81K shares of Dermata Therapeutics (DRMA), compromising 1.87% of the company, valued at $7K.

What percentage of Dermata Therapeutics is owned by UBS GROUP AG?

UBS GROUP AG is the third largest holder of Dermata Therapeutics. The company owns 3.44K of the company's shares outstanding (worth $4.44M).